Media Summary: Effect of ferric carboxymaltose on functional capacity in patients with HF and iron deficiency. Ezetimibe/Simvastatin vs Simvastatin monotherapy on cardiovascular outcomes after ACS. For more resources from the Losartan In Hypertrophic Cardiomyopathy. For more resources from the

Ehj Today Confirm Trial - Detailed Analysis & Overview

Effect of ferric carboxymaltose on functional capacity in patients with HF and iron deficiency. Ezetimibe/Simvastatin vs Simvastatin monotherapy on cardiovascular outcomes after ACS. For more resources from the Losartan In Hypertrophic Cardiomyopathy. For more resources from the Aspirin and primary prevention of cardiovascular events in the elderly exposed to multiple atherosclerotic risk factors. For moreĀ ... Rosk/Benefit of prolonged DAPT after DES. For more resources from the Darapladib effects relating to Lp-PLA2 activity levels in the Stabilization of Atherosclerotic Plaque by Initiation of DarapladibĀ ...

Alirocumab vs Ezetimibe in patients with statin intolerance. For more resources from the Good morning i'm carl swedberg from gothenburg sweden at the and this is aha 6-month DAPT post coronary stenting. For more resources from the Surgical treatment of moderate ischemic mitral regurgitation. For more resources from the

Photo Gallery

EHJ Today - CONFIRM Trial
EHJ Today - The IMPROVE IT Trial
EHJ Today - The INHERIT Trial
EHJ Today - The JPPP Trial
EHJ Today - The randomized ALBATROSS Trial
EHJ Today - The OPTIDUAL Trial
EHJ Today - The DAPT Study
EHJ Today - STABILITY Trial
EHJ Today - The SIRTAX Trial
EHJ Today - The CIRCUS Trial
EHJ Today - The EAST-AF Trial
EHJ Today - The ODYSSEY ALTERNATIVE Trial
View Detailed Profile
EHJ Today - CONFIRM Trial

EHJ Today - CONFIRM Trial

Effect of ferric carboxymaltose on functional capacity in patients with HF and iron deficiency.

EHJ Today - The IMPROVE IT Trial

EHJ Today - The IMPROVE IT Trial

Ezetimibe/Simvastatin vs Simvastatin monotherapy on cardiovascular outcomes after ACS. For more resources from the

EHJ Today - The INHERIT Trial

EHJ Today - The INHERIT Trial

Losartan In Hypertrophic Cardiomyopathy. For more resources from the

EHJ Today - The JPPP Trial

EHJ Today - The JPPP Trial

Aspirin and primary prevention of cardiovascular events in the elderly exposed to multiple atherosclerotic risk factors. For moreĀ ...

EHJ Today - The randomized ALBATROSS Trial

EHJ Today - The randomized ALBATROSS Trial

European Heart Journal

EHJ Today - The OPTIDUAL Trial

EHJ Today - The OPTIDUAL Trial

European Heart Journal

EHJ Today - The DAPT Study

EHJ Today - The DAPT Study

Rosk/Benefit of prolonged DAPT after DES. For more resources from the

EHJ Today - STABILITY Trial

EHJ Today - STABILITY Trial

Darapladib effects relating to Lp-PLA2 activity levels in the Stabilization of Atherosclerotic Plaque by Initiation of DarapladibĀ ...

EHJ Today - The SIRTAX Trial

EHJ Today - The SIRTAX Trial

... the follow-up of the initial

EHJ Today - The CIRCUS Trial

EHJ Today - The CIRCUS Trial

European Heart Journal

EHJ Today - The EAST-AF Trial

EHJ Today - The EAST-AF Trial

European Heart Journal

EHJ Today - The ODYSSEY ALTERNATIVE Trial

EHJ Today - The ODYSSEY ALTERNATIVE Trial

Alirocumab vs Ezetimibe in patients with statin intolerance. For more resources from the

EHJ Today - The EMPA-REG OUTCOME Trial

EHJ Today - The EMPA-REG OUTCOME Trial

Good morning i'm carl swedberg from gothenburg sweden at the and this is aha

EHJ Today - The Italic Trial

EHJ Today - The Italic Trial

6-month DAPT post coronary stenting. For more resources from the

EHJ Today - The EROSION Trial

EHJ Today - The EROSION Trial

This is eha

EHJ Today - The IMPROVE-IT Trial

EHJ Today - The IMPROVE-IT Trial

European Heart Journal

EHJ Today - ODYSSEY ESCAPE Trial

EHJ Today - ODYSSEY ESCAPE Trial

This is ehh

EHJ Today - The LEADLESS II Clinical Trial

EHJ Today - The LEADLESS II Clinical Trial

European Heart Journal

EHJ Today - The CTSM MMR Trial

EHJ Today - The CTSM MMR Trial

Surgical treatment of moderate ischemic mitral regurgitation. For more resources from the

EHJ Today - The PARADIGM Trial

EHJ Today - The PARADIGM Trial

PARADIGM